OpenVSafe by OpenVAERS
Search V-safe

HY8-62680-89847

3 vaccinations 3 coded responses 28 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
961 / CA
Registered
2021-03-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-25
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-18
    Dose 2 — Pfizer-BioNTech
  3. 2021-03-19
    Registered in v-safe
  4. 2021-03-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Syncope — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Fainting
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2021-03-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-03-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-03-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-03-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  10. 2021-03-25
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-04-01
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-04-15
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-04-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-04-29
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-06-17
    Survey response — 3 months, dose 2
    MedDRA: Fibrocystic breast disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Diagnosed w/fibrocystic brrasts
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-06-17
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  18. 2021-06-19
  19. 2021-06-22
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  20. 2021-09-16
    Survey response — 6 months, dose 2
    MedDRA: Hypothyroidism — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Hypothyroidism
    MedDRA releases: 2024-11 · check-in free text available
  21. 2021-09-16
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-09-21
  23. 2021-12-06
    Dose 3 — Moderna
  24. 2021-12-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  25. 2021-12-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Diarrhea
    Adult check-in
  26. 2021-12-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness · Headache
    Adult check-in
  27. 2021-12-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  28. 2021-12-12
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  29. 2021-12-13
    Health check-in — day 7, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  30. 2021-12-20
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  31. 2021-12-27
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-01-03
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  33. 2022-01-10
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  34. 2022-01-17
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-03-09
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-06-07
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  37. 2022-12-08
    Health check-in — 12 months, dose 3
    Feeling: Poor
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-25Pfizer-BioNTech
22021-03-18Pfizer-BioNTech
32021-12-06Moderna No

Call center

2 call center cases

1 successful · 1 unsuccessful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 2

2021-03-19

Systemic reaction (other): Fainting

Release 9 — 3 months, dose 2

2021-06-17

Symptoms: Diagnosed w/fibrocystic brrasts

Release 9 — 6 months, dose 2

2021-09-16

Symptoms: Hypothyroidism

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFibrocystic breast disease ✓ ✓ ✓
SDHypothyroidism · · ✓
SDPre-existing disease ○ ○ ○
SROSyncope ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release